Results 171 to 180 of about 3,173,890 (267)

Examining the relationship between adherence and the number of cardiometabolic medications: Findings for patients with type 2 diabetes within a Tribal health care system. [PDF]

J Manag Care Spec Pharm
Nelson T, Pierre C, Yao Y, Segal R, Aguila ME, Legaspi AB, DeVaughan Circles A, Donahoo WT, Turner Goins R, Wilkie DJ, Scarton L.   +10 more
europepmc   +1 more source

Studies on Hypolipidemic Agents. IV. Syntheses and Hypolipidemic Activities of 4-Substituted Phenoxyisobutyric Acid Derivatives

, 1974
Fumihiko Miyoshi, HIDEO FUKAMI, Y. SAKO
openalex   +2 more sources

Studies on hypolipidemic agents. V. Influence of 5-tridecylpyrazole-3-carboxylic acid, a new hypolipidemic agent, on intestinal cholesterol absorption in rats.

Chemical and Pharmaceutical Bulletin, 1988
Tetuya Suga, Kunio Seki, Takafumi Watanabe   +2 more
openaire   +4 more sources

Extreme Pregnancy-Induced Hypertriglyceridemia Resulting in Pancreatitis: A Case Report. [PDF]

Am J Case Rep
Matsuura S, Ghatnekar R, Yamasato K.
europepmc   +1 more source

Studies on Hypolipidemic Agents. I. Syntheses and Hypolipidemic Activities of 2-(4'-Chlorophenoxy) isobutyric Acid Derivatives

, 1974
Fumihiko Miyoshi, Hisao Kuroda, KATSUYUKI HIRAOKA, HIDEO FUKAMI, KUNIO ONISHI, Masaru Mori, KOICHIRO NAGAO, MUNEYOSHI SHIGA, Eiichi Sakakibara   +8 more
openalex   +2 more sources

Virgin Coconut Oil-based Nanostructured Lipid Carrier Improves the Hypolipidemic Effect of Rosuvastatin. [PDF]

Int J Nanomedicine
Shehata TM, Aldhubiab B, Elsewedy HS.
europepmc   +1 more source

Studies on Hypolipidemic Agents. III. Syntheses and Hypocholesteremic Activities of Morpholino and Trifluoromethyl Derivatives

, 1974
Fumihiko Miyoshi, KOICHIRO NAGAO
openalex   +2 more sources

Marine Compounds and Age-Related Diseases: The Path from Pre-Clinical Research to Approved Drugs for the Treatment of Cardiovascular Diseases and Diabetes. [PDF]

Mar Drugs
Giuliani ME, Bigossi G, Lai G, Marcozzi S, Brunetti D, Malavolta M.   +5 more
europepmc   +1 more source

Effects of Treatment with Probucol, a Hypolipidemic Agent, on Diabetic Nephropathy.

, 2002
Hidehisa Sasaki, Saburo Kanai, Yoshiaki Itoh, Yoh Miyashita, Kohji Shirai   +4 more
openalex   +2 more sources

Classical and Novel Lipid-Lowering Therapies for Diabetic Patients with Established Coronary Artery Disease or High Risk of Coronary Artery Disease-A Narrative Clinical Review. [PDF]

Pharmaceuticals (Basel)
Velidakis N, Stachteas P, Gkougkoudi E, Papadopoulos C, Kadoglou NPE.   +4 more
europepmc   +1 more source